On the Dell’s Children website, a mother and father share their story about how clinical trials brought hope to their family during their son’s cancer treatment.
Rex was 17 months old when he was diagnosed with high-risk neuroblastoma. The article says: “Upon Rex’s diagnosis, Lesley and her husband, Casey, knew their family faced a long, uphill battle. High-risk neuroblastoma is an aggressive and deadly form of childhood cancer, and the odds for survival were not in their child’s favor. They agreed to enroll Rex into a clinical trial study using an experimental drug, Unituxin, for children with high-risk neuroblastoma.”
In this personal story his parents Lesley and Casey talk about their gratitude to those children who were part of clinical trials for high-risk neuroblastoma treatment. Go to the page to find out more.